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Prevention of Folate Deficiency by Food
Fortification
VI. THE ANTIMEGALOBLASTIC EFFECT OF FOLIC
ACID-FORTIFIED MAIZE MEAL
N. COLMAN, R. GREEN, K. STEVENS, J. METZ
SUMMARY
The antimegaloblastic effect of cooked folic acid-fortified
maize meal was tested by feeding the meal to 5 lactating
patients with folate-deficient megaloblastic anaemia. The
dose of folic acid in the meal before cooking varied from
100 to ·500 p..g daily. One patient who received 100 p..g
daily had a suboptimal haematological response. Meal
containing 300 p..g and 500 p..g daily produced optimal
haematological response in all 4 patients so treated, and
there was no secondary reticulocyte response in the 2
patients subsequently given pharmacological doses of
folic acid. It is concluded that the fortified meal after
cooking is an effective antimegaloblastic agent.
S. Afr. Med. J., 48, 1795 (1974).
There is much interest in food fortification to prevent
nutritional deficiencies. As maize, which is poor in folate,l
is a staple item of the diet of millions of people in
developing countries, and as folate deficiency is common
in these peoples, we are investigating the use of folic
acid-fortified maize meal (FAMM) in the prevention of
folate deficiency. Feeding FAMM to pregnant subjects
results in a rise in the Lactobacillus casei folate activity
in their serum and red cells.' This indicates that the
FAMM provides a form of folate which can be utilised
by bacteria, but while this is suggestive, it does not prove
that this folate is biologically available to man. For this
reason, the efficacy of FAMM as a therapeutic agent in
patients with folate-deficient megaloblastic anaemia has
been evaluated.
PATIENTS AND METHODS
The antimegaloblastic effect of the cooked meal was
tested by means of a conventional therapeutic trial carried
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out in 5 patients with folate-deficient megalobla tic
anaemia. All were adult females who were admitted to
hospital with severe anaemia occurring during lactation,
and they continued to breast-feed throughout their stay
in hospital. The mean period between parturition and
admission to hospital was 114 days (range 49 - 189 days).
The laboratory findings on admission are summarised in
Table I.
On admission to hospital, the patients received the
usual hospital diet for periods of 3 - 8 days until the
diagnosis of folate deficiency was established by appro-
priate laboratory investigations. The diet was free of
uncooked' green leafy vegetables and contained copious
quantities of maize meal. This diet did not induce
haematological response in patients with folate-deficient
megaloblastic anaemia, who were followed for periods of
up to 30 days.'"
Patients 2 and 3, who were the most severely anaemic.
were given transfusions of whole blood at the time of
admission to hospital.
After the diagnosis of folate deficiency had been
established, the maize meal in the hospital diet was
supplemented with the FAMM. The daily dose of folic
acid added to the maize meal before cooking was 100 pg
in the case of patient 1, 300 I~g in the case of patients
2 and 3, and 500p..g in the case of patients 4 and 5.
The maize meal was fortified with pteroylglutamic acid in
proportions of one daily dose for each 30 g of maize meal
(dry weight). The mixture was cooked in boiling water
for 30 - 45 minutes to form a stiff paste, and was eaten
with the usual hospital meals each day. We have found
that folic acid resists destruction by boiling in water
for two hours:
In patients 4 and 5, an attempt was made to elicit
a secondary reticulocyte response when the reticulocyte
counts had returned to stable levels after feeding the
FAMM. These patients were given 15 mg folic acid
and 240 mg elemental iron (as ferrous sulphate) daily by
mouth.
Standard laboratory methods were used. Haemoglobin.
cell counts and red cell indices were measured with a
Coulter S counter. Serum folate'" and red cell folate'
were assayed with L. casei, and serum vitamin RIO
measured by a radio-isotope dilution method.'·
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TABLE I. RESULTS OF HAEMATOLOGICAL INVESTIGATIONS IN 5 PATIENTS ON ADMISSION TO HOSPITAL (IN ALL
PATIENTS THE BLOOD SMEAR. SHOWED OVAL MACROCYTES AND HYPERSEGMENTED NEUTROPHILS, AND THE BONE
MARROW WAS MEGALOBLASTIC)
The daily red cell and reticulocyte counts of the 5 patients
are depicted graphically in Figs I - 5. None of the patients
had a reticulocyte response while receiving the hospital
diet only, but all showed haematological response after
feeding with FAMM. In order for a haematological
response in a patient with megaloblastic anaemia to be
rated as optimal, three criteria should be satisfied, viz.
the reticulocyte peak should occur between days 5 and
8," reach certain levels," and the red cell count must
rise at a specified rate." The height of the reticulocyte
peak and the rate of rise in red cell count are related
to the severity of anaemia. According to these criteria,
all the patients in the present study showed an optimal
response, except for patient 1 who received the lowest
dose of folic acid in FAMM (100 ,ug/day). In this patient
the height of the reticulocyte peak and the rate of rise
in the red cell count were suboptimal.
Neither of the 2 patients who received pharma-
cological doses of folic acid and iron showed a secondary
reticulocyte response, after the initial response to the
FAMM.
Four patients were thrombocytopenic at the start of
the trial, and all had normal platelet counts by day 8.
The single patient with a leucoPenia on day 0 had a




2 3 4 5
3,4 3,7 5,1 4,4
0,79 1,00 1,25 1,25
10,1 11,8 15,3 13,7
128 118 122 107
43,0 37,0 40,8 34,4
33,7 31,4 33,3 32,1
5000 2700 9800 7400
40000 54000 85000 188000
2,8 0,6 1,0 3,4
1,0 1,2 0,6 0,6
100 116 12 84
134 216 195 241
175 57 77 31
505 554 1205 1068














Haemoglobin (g/100 ml) ...
Red cell count (million/,ul)
Haematocrit (%)
Mean cell volume (,urn') ...
Mean cell haemoglobin (pg)




Serum folate (ng/ml) ...
Red cell folate (ng/ml)
Serum iron (,ug/loo ml)
Serum unsaturated iron-binding capacity (,ug/l00
ml)
Serum vitamin B I2 (pg/ml) (normal range 400-
1 020 pg/mI) ...
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DISCUSSION
None of the patients in the present study showed a rise
in reticulocyte count during the period in hospital before
Days
Fig. 1'. Reticulocyte response (broken line) and rise in red
cell count (solid line) in a patient with folate-deficient
megaloblastic anaemia after eating maize meal fortified
with lOO /lg folic acid/day.
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Fig. 2. Reticulocyte response (broken line) and rise in red
cell count (solid line) in a patient with folate-deficient
megaloblastic anaemia after eating maize meal fortified































































Fig. 3. Reticulocyte response (broken line) and rise in red
cell count (solid line) in a patient with folate-deficient
megaloblastic anaemia after eating maize meal fortified
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Fig. 4. Reticulocyte response (broken line) and rise in red
cell count (solid line) in a patient with folate-deficient
megaloblastic anaemia after eating maize meal fortified
with 500 /lg folic acid per day. There was no secondary
reticulocyte response to pharmacological doses (IS mg/day)
of folic acid.
they received FAMM. This is in accord with previous
experience with the hospital diet;·, which contains in-
sufficient amounts of folate to induce a haematological
response.
Patient 1, in whom the haematological response was
suboptimal, received FAMM containing 100 p.g folic
acid daily before it was cooked. Failure to induce optimal
haematological response reflects the fact that this dose
is inadequate to meet the folate requirement of the
lactating patient, which has been estimated to be approxi-
mately 300 j.Lg/day."
The failure to induce a secondary reticulocyte response
with pharmacological doses of folic acid in the 2 patients
so studied (Nos. 4 and 5) is further evidence of the optimal
nature of the response induced by the FAMM containing
500 j.Lg folic acid daily.
In patients 2 and 3, the therapeutic trial followed the
administration of blood transfusions. It has been suggested
that transfusions may induce a 'spontaneous' response
in a patient with megaloblastic anaemia." However, in a
previous study, 3 lactating patients with folate-deficient
megaloblastic anaemia who were transfused did not have
reticulocyte responses when followed for periods of up
to 17 days!
The results of these trials indicate that cooking folic
acid in the presence of maize meal does not alter its
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Fig. 5. Reticulocyte response (broken line) and rise in red
cell connt (solid line) in a patient with folate-deficient
megaloblastic anaemia after eating maize meal fortified
with 500 fJ.g folic acid per day. There was no secondary
reticulocyte response to pharmacological doses (15 mgj
day) of folic acid.
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